Gene · 55818
Papers1,506
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,506
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Can Dietary Actives Affect miRNAs and Alter the Course or Prevent Colorectal Cancer? | Int J Mol Sci | 2023 | 37373289 | PubTator, text mining | PubMed |
| REST Targets JAK-STAT and HIF-1 Signaling Pathways in Human Down Syndrome Brain and Neural Cells. | Int J Mol Sci | 2023 | 37373133 | PubTator, text mining | PubMed |
| Dysregulation of histone modifications in bone marrow mesenchymal stem cells during skeletal ageing: roles and therapeutic prospects. | Stem Cell Res Ther | 2023 | 37357311 | PubTator, text mining | PubMed |
| Histone demethylases in the regulation of immunity and inflammation. | Cell Death Discov | 2023 | 37353521 | PubTator, text mining | PubMed |
| PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities. | Front Pharmacol | 2023 | 37351512 | PubTator, text mining | PubMed |
| Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells. | Int J Oncol | 2023 | 37326062 | PubTator, text mining | PubMed |
| Recruitment of transcription factor ETS1 to activated accessible regions promotes the transcriptional program of cilia genes. | Nucleic Acids Res | 2023 | 37326025 | PubTator, text mining | PubMed |
| LncRNA H19 ameliorates myocardial infarction-induced myocardial injury and maladaptive cardiac remodelling by regulating KDM3A. | J Cell Mol Med | 2023 | 37325951 | PubTator, text mining | PubMed |
| A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer. | Front Genet | 2023 | 37323657 | PubTator, text mining | PubMed |
| Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis. | Oncol Res | 2023 | 37305393 | PubTator, text mining | PubMed |
| Epigenetic markers and therapeutic targets for metastasis. | Cancer Metastasis Rev | 2023 | 37286865 | PubTator, text mining | PubMed |
| Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress. | Oxid Med Cell Longev | 2023 | 37273554 | PubTator, text mining | PubMed |
| Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility. | Hum Genomics | 2023 | 37270590 | PubTator, text mining | PubMed |
| KDM3A, a Novel Blood-Based Biomarker in Colorectal Carcinogenesis. | Balkan J Med Genet | 2023 | 37265967 | PubTator, text mining | PubMed |
| Vitamin C: From nutrition to oxygen sensing and epigenetics. | Redox Biol | 2023 | 37263060 | PubTator, text mining | PubMed |
| Krüppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing. | Front Immunol | 2023 | 37251374 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis-A Narrative Review. | Metabolites | 2023 | 37233716 | PubTator, text mining | PubMed |
| Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. | Signal Transduct Target Ther | 2023 | 37230968 | PubTator, text mining | PubMed |
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Histone Demethylase Modulation: Epigenetic Strategy to Combat Cancer Progression. | Epigenomes | 2023 | 37218871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55818/papers?page=9